Net Loss per Share - Schedule of Error Corrections and Prior Period Adjustments (Details) - $ / shares |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 |
Sep. 30, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2025 |
Sep. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Anti-dilutive securities | |||||||||
| Basic weighted average number of shares outstanding (Note 13) (in shares) | 29,032,422 | 28,508,089 | 28,232,604 | 28,085,234 | 28,159,333 | 28,276,865 | 28,409,706 | 26,908,070 | 21,562,581 |
| Diluted weighted average number of shares outstanding (Note 13) (in shares) | 29,032,422 | 28,508,089 | 28,232,604 | 28,085,234 | 28,159,333 | 28,276,865 | 28,409,706 | 26,908,070 | 21,562,581 |
| Basic net loss per common, Series A preferred, and Series B preferred share (in dollars per share) | $ (3.25) | $ (4.01) | $ (1.50) | $ (2.61) | $ (4.10) | $ (8.12) | $ (10.15) | $ (17.31) | $ (17.33) |
| Diluted net loss per common, Series A preferred, and Series B preferred share (in dollars per share) | $ (3.25) | $ (4.01) | $ (1.50) | $ (2.61) | $ (4.10) | $ (8.12) | $ (10.15) | $ (17.31) | $ (17.33) |
| As Reported | |||||||||
| Anti-dilutive securities | |||||||||
| Basic weighted average number of shares outstanding (Note 13) (in shares) | 22,482,502 | 22,207,017 | 22,091,314 | 22,149,492 | 22,261,718 | 22,434,310 | 21,272,962 | 18,687,774 | |
| Diluted weighted average number of shares outstanding (Note 13) (in shares) | 22,482,502 | 22,207,017 | 22,091,314 | 22,149,492 | 22,261,718 | 22,434,310 | 21,272,962 | 18,687,774 | |
| Basic net loss per common, Series A preferred, and Series B preferred share (in dollars per share) | $ (5.08) | $ (1.90) | $ (3.32) | $ (5.22) | $ (10.32) | $ (12.85) | $ (21.90) | $ (19.99) | |
| Diluted net loss per common, Series A preferred, and Series B preferred share (in dollars per share) | $ (5.08) | $ (1.90) | $ (3.32) | $ (5.22) | $ (10.32) | $ (12.85) | $ (21.90) | $ (19.99) | |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|